2022
DOI: 10.1038/s41598-022-08114-2
|View full text |Cite
|
Sign up to set email alerts
|

The alveolar macrophage toponome of female SP-A knockout mice differs from that of males before and after SP-A1 rescue

Abstract: Using the Toponome Imaging System (TIS), a serial immunostainer, we studied the patterns of expression of multiple markers in alveolar macrophages (AM) from female mice lacking surfactant protein A (SP-A knockouts; KO) after “rescue” with exogenous SP-A1. We also used a 7-marker subset to compare with AM from males. AM were harvested 18 h after intrapharyngeal SP-A1 or vehicle, attached to slides, and subjected to serial immunostaining for 12 markers. Expression of the markers in each pixel of the image was an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(10 citation statements)
references
References 56 publications
0
10
0
Order By: Relevance
“…TIS was performed as described previously ( 14 16 ). As discussed in previous studies, the choice of antibodies was limited by the presence of artifacts in fluorescent images from some samples that may prevent the use of some of these images/markers for study.…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…TIS was performed as described previously ( 14 16 ). As discussed in previous studies, the choice of antibodies was limited by the presence of artifacts in fluorescent images from some samples that may prevent the use of some of these images/markers for study.…”
Section: Methodsmentioning
confidence: 99%
“…Table 1 lists the nine antibodies or reagents we used in the image analysis, their gene names (where appropriate), their Uniprot accession numbers, the commercial source, and the catalog number of each antibody. Calibration and optimization of antibodies for the TIS procedure was done as previously described ( 14 16 ). Briefly, commercially available antibodies were tested at several dilutions.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations